326 related articles for article (PubMed ID: 17709142)
1. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of novel platinum(II) complexes of glutamate tethered to hydrophilic hematoporphyrin derivatives.
Kim YS; Song R; Lee CO; Sohn YS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2889-92. PubMed ID: 15125953
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
4. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of novel thermosensitive platinum(II)-cyclotriphosphazene conjugates.
Song SC; Lee SB; Lee BH; Ha HW; Lee KT; Sohn YS
J Control Release; 2003 Jul; 90(3):303-11. PubMed ID: 12880697
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
7. A micellar prodrug of paclitaxel conjugated to cyclotriphosphazene.
Jun YJ; Min JH; Ji da E; Yoo JH; Kim JH; Lee HJ; Jeong B; Sohn YS
Bioorg Med Chem Lett; 2008 Dec; 18(24):6410-3. PubMed ID: 18990574
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
[TBL] [Abstract][Full Text] [Related]
11. Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells.
Huynh VT; Quek JY; de Souza PL; Stenzel MH
Biomacromolecules; 2012 Apr; 13(4):1010-23. PubMed ID: 22324363
[TBL] [Abstract][Full Text] [Related]
12. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
[TBL] [Abstract][Full Text] [Related]
14. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate.
Song R; Joo Jun Y; Ik Kim J; Jin C; Sohn YS
J Control Release; 2005 Jun; 105(1-2):142-50. PubMed ID: 15894394
[TBL] [Abstract][Full Text] [Related]
16. In vitro anticancer activities and optical imaging of novel intercalative non-cisplatin conjugates.
Gao J; Woolley FR; Zingaro RA
J Med Chem; 2005 Nov; 48(23):7192-7. PubMed ID: 16279777
[TBL] [Abstract][Full Text] [Related]
17. A novel micelle-encapsulated platinum(II) anticancer agent.
Jadhav VB; Jun YJ; Song JH; Park MK; Oh JH; Chae SW; Kim IS; Choi SJ; Lee HJ; Sohn YS
J Control Release; 2010 Oct; 147(1):144-50. PubMed ID: 20654662
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity of cis-dichloroplatinum (II) complexes of (1S,3S)-1,2,3,4-tetrahydroisoquinolines.
Xu G; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2011 Jan; 46(1):356-63. PubMed ID: 21144623
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
[TBL] [Abstract][Full Text] [Related]
20. New polymer-platinum (II) antitumor conjugates.
Xiao H; Fan Y; Liu S; Chen X; Huang Y; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e103-4. PubMed ID: 22195780
[No Abstract] [Full Text] [Related]
[Next] [New Search]